Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes

Archives of Dermatological Research

Volumn 305, Issue 6, 2013, Pages 519-528

  Hochberg, Malka ^a   Gilead, Leon ^a   Markel, Gal ^b,d   Nemlich, Yael ^b,d   Feiler, Yulia ^b   Enk, Claes David ^a   Denichenko, Polina ^c   Karni, Rotem ^c   Ingber, Arieh ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

BCC and SCC; IGFBP7; Proliferation; RNA editing; Senescence

Indexed keywords

INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CELL CULTURE; CELL IMMORTALIZATION; CELL PROLIFERATION; CHEMOSURGERY; CONTROLLED STUDY; EPIDERMIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IGFBP7 GENE; KERATINOCYTE; NON MELANOMA SKIN CANCER; PRIORITY JOURNAL; RNA EDITING; RNA TRANSCRIPTION; SENESCENCE; SQUAMOUS CELL CARCINOMA; TISSUE SECTION; TUMOR SUPPRESSOR GENE;

ADENOSINE DEAMINASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; KERATINOCYTES; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; RNA-BINDING PROTEINS; SKIN NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84880922424     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-013-1338-5     Document Type: Article

References (55)

1. Athanasiadis A, Rich A, Maas S (2004) Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol 2:e391
2. Bass BL (2002) RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem 71:817-846
3. Blow M, Futreal PA, Wooster R, Stratton MR (2004) A survey of RNA editing in human brain. Genome Res 14:2379-2387
4. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell-line. J Cell Biol 106:761-771
5. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M, Breuninger H (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 9:713-720
6. Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M, Papas T, Seth A (1998) Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 16:2459-2467
7. Chen Y, Cui T, Knosel T, Yang L, Zoller K, Petersen I (2011) IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Lung Cancer 73:38-44
8. Costa EMF, Bedecarrats GY, Mendonca BB, Arnhold IJP, Kaiser UB, Latronico AC (2001) Two novel mutations in the gonadotropin-releasing hormone receptor gene in brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J Clin Endocrinol Metab 86:2680-2686
9. Culjkovic B, Topisirovic I, Skrabanek L, Ruiz-Gutierrez M, Borden KL (2006) eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Cell Biol 175:415-426
10. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363-9367
11. Enk CD, Jacob-Hirsch J, Gal H, Verbovetski I, Amariglio N, Mevorach D, Ingber A, Givol D, Rechavi G, Hochberg M (2006) The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 25:2601-2614
12. Enk CD, Jacob-Hirsch J, Gal H, Verbovetski I, Amariglio N, Mevorach D, Ingber A, Givol D, Rechavi G, Hochberg M (2006) The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes. Oncogene 25:2601-2614
13. Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA (2005) Role of apoptosis in basal cell and squamous cell carcinoma formation. Immunol Lett 100:68-72
14. Folcarelli S, Battistoni A, Carri MT, Polticelli F, Falconi M, Nicolini L, Stella L, Rosato N, Rotilio G, Desideri A (1996) Effect of lys- > arg mutation on the thermal stability of Cu, Zn superoxide dismutase: influence on the monomer-dimer equilibrium. Protein Eng 9:323-325
15. Gallo A, Galardi S (2008) A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol 5:135-139
16. Heesch S, Schlee C, Neumann M, Stroux A, Kuhnl A, Schwartz S, Haferlach T, Goekbuget N, Hoelzer D, Thiel E, Hofmann WK, Baldus CD (2010) BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia. Leukemia 24:1429-1436
17. Hochberg M, Zeligson S, Amariglio N, Rechavi G, Ingber A, Enk CD (2007) Genomic-scale analysis of psoriatic skin reveals differentially expressed insulin-like growth factor-binding protein-7 after phototherapy. Br J Dermatol 156:289-300
18. How HK, Yeoh A, Quah TC, Oh Y, Rosenfeld RG, Lee KO (1999) Insulin-like growth factor binding proteins (IGFBPs) and IGFBP-related protein 1-levels in cerebrospinal fluid of children with acute lymphoblastic leukemia. J Clin Endocrinol Metab 84:1283-1287
19. Howle JR, Morgan GJ, Kalnins I, Palme CE, Veness MJ (2008) Metastatic cutaneous squamous cell carcinoma of the scalp. ANZ J surg 78:449-453
20. Hu S, Chen R, Man X, Feng X, Cen J, Gu W, He H, Li J, Chai Y, Chen Z (2011) Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia. Pediatr Hematol Oncol 28:279-287
21. Imagawa TOSH, Teramachi SATO, Taniguchi KAZU (2003) Single mutation of lys or arg residue in ATP binding pocket in rat Na/K-ATPase alpha-1 subunit induces different affinity change in high- and low-affinity ATP binding. Ann N Y Acad Sci 986:240-241
22. Irimia M, Denuc A, Ferran JL, Pernaute B, Puelles L, Roy SW, Garcia-Fernandez J, Marfany G (2012) Evolutionarily conserved A-to-I editing increases protein stability of the alternative splicing factor nova1. RNA Biol 9:12-21
23. Kato MV (2000) A secreted tumor-suppressor, mac25, with activin-binding activity. Mol Med 6:126-135
24. Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A (2004) Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res 14:1719-1725
25. Komatsu S, Okazaki Y, Tateno M, Kawai J, Konno H, Kusakabe M, Yoshiki A, Muramatsu M, Held WA, Hayashizaki Y (2000) Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 267:109-117
26. Koren-Michowitz M, Shimoni A, Vivante A, Trakhtenbrot L, Rechavi G, Amariglio N, Loewenthal R, Nagler A, Cohen Y (2008) A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD). Leuk Res 32:421-427
27. Landberg G, Ostlund H, Nielsen NH, Roos G, Emdin S, Burger AM, Seth A (2001) Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Oncogene 20:3497-3505
28. Lehmann KA, Bass BL (2000) Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 39:12875-12884
29. Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D (2004) Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol 22:1001-1005
30. Levanon EY, Hallegger M, Kinar Y, Shemesh R, Djinovic-Carugo K, Rechavi G, Jantsch MF, Eisenberg E (2005) Evolutionarily conserved human targets of adenosine to inosine RNA editing. Nucleic Acids Res 33:1162-1168
31. Libra M, Malaponte G, Bevelacqua V, Siciliano R, Castrogiovanni P, Fulvi A, Micali G, Ligresti G, Mazzarino MC, Stivala F, Travali S, McCubrey JA (2006) Absence of BRAF gene mutation in non-melanoma skin tumors. Cell Cycle 5:968-970
32. Lin J, Lai M, Huang Q, Ruan W, Ma Y, Cui J (2008) Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro. Cancer Biol Ther 7:1896-1900
33. Mansfield KD, Keene JD (2009) The ribonome: a dominant force in co-ordinating gene expression. Biol Cell 101:169-181
34. Margadant C, Charafeddine RA, Sonnenberg A (2010) Unique and redundant functions of integrins in the epidermis. FASEB J 24:4133-4152
35. Morse DP, Aruscavage PJ, Bass BL (2002) RNA hairpins in noncoding regions of human brain and caenorhabditis elegans mRNA are edited by adenosine deaminases that act on RNA. Proc Natl Acad Sci USA 99:7906-7911
36. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL (1993) Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ 4:715-722
37. Mutaguchi K, Yasumoto H, Mita K, Matsubara A, Shiina H, Igawa M, Dahiya R, Usui T (2003) Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 63:7717-7723
38. Nousbeck J, Sarig O, Avidan N, Indelman M, Bergman R, Ramon M, Enk CD, Sprecher E (2009) Insulin-like growth factor-binding protein 7 regulates keratinocyte proliferation, differentiation and apoptosis. J Invest Dermatol 130:378-387
39. Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A (2007) Altered adenosine-to-inosine RNA editing in human cancer. Genome Res 17:1586-1595
40. Paz-Yaacov N, Levanon EY, Nevo E, Kinar Y, Harmelin A, Jacob-Hirsch J, Amariglio N, Eisenberg E, Rechavi G (2010) Adenosine-to-inosine RNA editing shapes transcriptome diversity in primates. Proc Natl Acad Sci USA 107:12174-12179
41. Polson AG, Bass BL (1994) Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J 13:5701-5711
42. Qureshi IA, Mehler MF (2010) Impact of nuclear organization and dynamics on epigenetic regulation in the central nervous system: implications for neurological disease states. Ann. N Y Acad.Sci. 1204(Suppl):E20-E37
43. Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G (2005) Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol 152:43-51
44. Ruan WJ, Lin J, Xu EP, Xu FY, Ma Y, Deng H, Huang Q, Lv BJ, Hu H, Cui J, Di MJ, Dong JK, Lai MD (2006) IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. J Zhejiang Univ Sci B 7:929-932
45. Sato Y, Chen Z, Miyazaki K (2007) Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25. Cancer Sci 98:1055-1063
46. Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S, Irvine M, Scolyer RA, Mann GJ, Becker JrC, Kefford RF, Rizos H (2010) IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell 141:717-727
47. Seol MA, Chu IS, Lee MJ, Yu GR, Cui XD, Cho BH, Ahn EK, Leem SH, Kim IH, Kim DG (2011) Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma. BMC Cancer 11:78
48. Sie CG, Hesler S, Maas S, Kuchka M (2012) IGFBP7's susceptibility to proteolysis is altered by A-to-I RNA editing of its transcript. FEBS Lett 586:2313-2317
49. Subramanian A, Sharma AK, Banerjee D, Jiang WG, Mokbel K (2007) Evidence for a tumour suppressive function of IGF1-binding proteins in human breast cancer. Anticancer Res 27:3513-3518
50. Tomimaru Y, Eguchi H, Wada H, Kobayashi S, Marubashi S, Tanemura M, Umeshita K, Kim T, Wakasa K, Doki Y, Mori M, Nagano H (2011) IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Int J Cancer 130:319-327
51. Trahtemberg U, Atallah M, Krispin A, Verbovetski I, Mevorach D (2007) Calcium, leukocyte cell death and the use of annexin V: fatal encounters. Apoptosis 12:1769-1780
52. Tran H, Chen K, Shumack S (2003) Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 149:50-52
53. Vizioli MG, Sensi M, Miranda C, Cleris L, Formelli F, Anania MC, Pierotti MA, Greco A (2010) IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Oncogene 29:3835-3844
54. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132:363-374
55. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR (2010) Role for IGFBP7 in senescence induction by BRAF. Cell 141:746-747